Work

ApoE and gut-microbiome interplay: implications for atherosclerosis and Alzheimer's disease

Year: 2026
Type: article
Abstract: Apolipoprotein E (APOE) is a key regulator of lipid metabolism and cholesterol transport and is strongly associated with cardiovascular and neurodegenerative diseases. Growing evidence has suggested that APOE also influences gut microbiome composition and function. This review summarizes the structural and functional characteristics of APOE isoforms and discusses current evidence linking APOE genotype to alterations in the gut microbiome and their implications for host health. The three major human APOE isoforms (APOE2, APOE3, and APOE4) exhibit distinct effects on lipoprotein metabolism, receptor interactions, inflammation, and atherosclerosis. Experimental and clinical studies further demonstrate that APOE genotype shapes gut microbial diversity, taxonomic composition, short-chain fatty acid production, bile acid metabolism, and inflammatory responses. Compared with APOE2 and APOE3, APOE4 is consistently associated with gut dysbiosis, reduced beneficial microbial taxa, increased lipopolysaccharide (LPS) sensitivity, altered microbial metabolite production, and changes in tryptophan metabolism, providing potential links to intestinal barrier dysfunction, systemic inflammation, and neurodegeneration. Collectively, current evidence identifies APOE as one of the critical regulators of host-microbiome interactions that extend beyond its classical role in lipid metabolism. A better understanding of APOE-dependent microbiome alterations may facilitate the development of genotype-specific therapeutic strategies for cardiovascular and neurodegenerative diseases.
Language: English
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7236419354
FWCI:
Cites: 198
Cited by:
Related to: 10
Parts: 1